Siolta Therapeutics

San Francisco Bay Area, United States · Founded 2016 · $88.5M raised

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$88.5M
Last Round
$12.0M Series CMar 2024
Rounds
4

About

Siolta Therapeutics is a clinical-stage biotech company developing live biotherapeutic products (LBPs) targeting inflammatory and allergic diseases through manipulation of the human microbiome. Their proprietary Precision Symbiotics Platform designs multi-strain microbial consortia to prevent conditions such as atopic dermatitis and food allergy in newborns. Founded as a UCSF spinout, their lead program STMC-103H has received FDA Fast Track Designation.

Summary

Siolta Therapeutics is a Biotech company based in San Francisco Bay Area, United States, founded in 2016. It has raised $88.5M in total across 4 rounds, most recently a $12.0M Series C round in Mar 2024. Investors include Capital Group and Khosla Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series CSeries CMar 2024
$12.0M

Sign up to see all 4 rounds

Seed through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Siolta Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/siolta-therapeutics"><img src="https://indexed.vc/api/badge/company/siolta-therapeutics" alt="Siolta Therapeutics on Indexed.vc" width="260" height="76" /></a>